SCHEMBL17526953

SCHEMBL17526953

CCCC[C@@H](CO)CCCO

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.68
LMNA P02545 4/20 0.68
SMN1; SMN2 Q16637 1/20 0.48
TSHR P16473 4/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 2/20 0.42
CYP3A4 P08684 3/20 0.41
CA2 P00918 2/20 0.39
DNM1 Q05193 1/20 0.36
FDPS P14324 1/20 0.36
CYP2D6 P10635 2/20 0.35
SPHK1 Q9NYA1 1/20 0.35
GMNN O75496 1/20 0.35
POLB P06746 1/20 0.35
THPO P40225 1/20 0.35
MTOR P42345 1/20 0.35
BLM P54132 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8162961 1.00 ALDH1A1 (0.68) ALDH1A1LMNASMN1; SMN2TSHRHSD17B10
SCHEMBL17526522 0.92 LMNA (0.73) ALDH1A1LMNASMN1; SMN2TSHRHSD17B10
SCHEMBL17526538 0.92 LMNA (0.73) ALDH1A1LMNASMN1; SMN2TSHRHSD17B10
SCHEMBL1101572 0.92 LMNA (0.73) ALDH1A1LMNASMN1; SMN2TSHRHSD17B10
SCHEMBL8161588 0.92 LMNA (0.81) ALDH1A1LMNASMN1; SMN2TSHRHSD17B10
SCHEMBL317382 0.92 ALDH1A1 (0.79) ALDH1A1LMNASMN1; SMN2TSHRTDP1
SCHEMBL20983224 0.90 LMNA (0.86) ALDH1A1LMNASMN1; SMN2TSHRHSD17B10
SCHEMBL22462340 0.90 LMNA (0.86) ALDH1A1LMNASMN1; SMN2TSHRHSD17B10
SCHEMBL22462336 0.90 LMNA (0.86) ALDH1A1LMNASMN1; SMN2TSHRHSD17B10
SCHEMBL22462342 0.90 LMNA (0.86) ALDH1A1LMNASMN1; SMN2TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 ALDH1A1 2376/4885LMNA 3497/4885SMN1; SMN2 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.